Serum clusterin as a marker for diagnosing hepatocellular carcinoma

Conclusions Although the diagnostic performance of serum AFP outperformed that of serum CLU, their combined parallel approach improved the sensitivity which is required in screening high risk populations such as CHC patients.
Source: Alexandria Journal of Medicine - Category: Journals (General) Source Type: research